chr20-873079-C-T
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 2P and 6B. PM2BP4_StrongBP6_Moderate
The NM_015985.4(ANGPT4):c.1393G>A(p.Val465Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000039 in 1,613,958 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Consequence
NM_015985.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ANGPT4 | NM_015985.4 | c.1393G>A | p.Val465Ile | missense_variant | 9/9 | ENST00000381922.5 | NP_057069.1 | |
ANGPT4 | XM_011529239.4 | c.1237G>A | p.Val413Ile | missense_variant | 8/8 | XP_011527541.1 | ||
ANGPT4 | NM_001322809.2 | c.*29G>A | 3_prime_UTR_variant | 8/8 | NP_001309738.1 | |||
LOC124904854 | XR_007067485.1 | n.267C>T | non_coding_transcript_exon_variant | 2/3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ANGPT4 | ENST00000381922.5 | c.1393G>A | p.Val465Ile | missense_variant | 9/9 | 1 | NM_015985.4 | ENSP00000371347.3 |
Frequencies
GnomAD3 genomes AF: 0.0000394 AC: 6AN: 152126Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.0000836 AC: 21AN: 251110Hom.: 0 AF XY: 0.000118 AC XY: 16AN XY: 135734
GnomAD4 exome AF: 0.0000390 AC: 57AN: 1461714Hom.: 0 Cov.: 31 AF XY: 0.0000481 AC XY: 35AN XY: 727140
GnomAD4 genome AF: 0.0000394 AC: 6AN: 152244Hom.: 0 Cov.: 31 AF XY: 0.0000269 AC XY: 2AN XY: 74446
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 05, 2022 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at